Holen Sie sich die Stockscreener-App
9.6691
1.95%
0.1791
Clearpoint Neuro Inc Aktie (CLPT) Neueste Nachrichten
Clearpoint Neuro, Valneva, Rocket Lab and other big stocks moving lower in Wednesday's pre-market session - MSN
Why The ClearPoint Neuro (CLPT) Story Is Shifting After New Partner And FDA Updates - Yahoo Finance
ClearPoint Neuro plunges as FY26 guidance falls below analysts' estimates - MSN
Trading Systems Reacting to (CLPT) Volatility - Stock Traders Daily
ClearPoint Neuro (CLPT) moves 8.1% higher: Will this strength last? - MSN
ClearPoint Neuro (CLPT) CEO exercises options and holds all shares - Stock Titan
Fundamentals Check: Will ClearPoint Neuro Inc benefit from current market trendsInsider Selling & Weekly Momentum Stock Picks - baoquankhu1.vn
CLPT Stock Price, Quote & Chart | CLEARPOINT NEURO INC (NASDAQ:CLPT) - ChartMill
Analysts Are Bullish on Top Healthcare Stocks: ClearPoint Neuro (CLPT), Xtant Medical Holdings (XTNT) - The Globe and Mail
ClearPoint Neuro, Inc. (NASDAQ:CLPT) Q4 2025 Earnings Call Transcript - Insider Monkey
Clearpoint Neuro’s IRRAS Acquisition: Integration Risks Threaten Promised Scale and Synergies - TipRanks
ClearPoint Neuro FY 2025 Revenue Growth Reinforces Bullish Narratives Despite Persistent EPS Losses - simplywall.st
Intuitive Surgical Stock: Buy, Sell, or Hold? - AOL.com
ClearPoint Neuro Reports Record 2025 Results, Expands Growth Outlook - The Globe and Mail
ClearPoint Neuro Q4 Earnings Call Highlights - MarketBeat
ClearPoint Neuro (NASDAQ:CLPT) Given New $20.00 Price Target at B. Riley Financial - MarketBeat
ClearPoint Neuro (CLPT) Sees Raised Price Target from B. Riley S - GuruFocus
Clearpoint Neuro, Valneva, Rocket Lab And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - Benzinga
B. Riley Raises Price Target on ClearPoint Neuro to $20 From $18, Keeps Buy Rating - marketscreener.com
ClearPoint Neuro, Inc. Q4 2025 earnings preview - MSN
ClearPoint Neuro (CLPT) Surpasses Q4 Revenue Expectations with S - GuruFocus
Clearpoint Neuro earnings missed by $0.08, revenue topped estimates - Investing.com Canada
ClearPoint Neuro, Inc. (CLPT) Q4 2025 Earnings Call Transcript Summary - 富途牛牛
CLPT Revenue Rises, Losses Widen Amid Cautious 2026 Outlook - Bitget
ClearPoint Neuro, Inc. (CLPT) reports Q4 loss, tops revenue estimates - MSN
ClearPoint Neuro, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
ClearPoint Neuro outlines $52M–$56M 2026 revenue target as company advances growth strategy and integrates IRRAS acquisition - MSN
Clearpoint Neuro Charts Aggressive Growth Amid Rising Costs - TipRanks
ClearPoint Neuro (CLPT) Projects Strong Growth for 2026 - GuruFocus
Earnings call transcript: ClearPoint Neuro Q4 2025 sees revenue growth, stock up By Investing.com - Investing.com South Africa
Earnings call transcript: ClearPoint Neuro Q4 2025 sees revenue growth, stock up - Investing.com Australia
ClearPoint Neuro 2025 Results & 2026 Growth Strategy for Neuro EcosystemNews and Statistics - IndexBox
ClearPoint Neuro (CLPT) Quarterly Earnings Conference Call Transcript - Bitget
CLPT: Record 2025 growth and IRRAS integration set the stage for double-digit expansion in 2026 - TradingView
ClearPoint Neuro (CLPT) Earnings Call Transcript - The Globe and Mail
ClearPoint Neuro, Inc. (CLPT) Reports Q4 Loss, Tops Revenue Estimates - Yahoo Finance
ClearPoint 10-K: Revenue $36.97M, EPS $(0.90) — Annual Results - TradingView
ClearPoint Neuro (NASDAQ:CLPT) Posts Quarterly Earnings Results, Misses Estimates By $0.05 EPS - MarketBeat
ClearPoint Neuro (NASDAQ: CLPT) expands into neurocritical care - Stock Titan
Clearpoint Neuro Inc reports results for the quarter ended December 31Earnings Summary - TradingView
ClearPoint Neuro Inc. (CLPT) Stock Falls on Q4 2025 Earnings - Quiver Quantitative
ClearPoint Neuro Q4 Revenue Rises; Issues 2026 Revenue Guidance - marketscreener.com
ClearPoint Neuro, Inc. Provides Earnings Guidance for the Fiscal Year 2026 - marketscreener.com
ClearPoint Neuro Q4 revenue rises on IRRAS acquisition - TradingView
CLPT: Record 2025 revenue and IRRAS acquisition set stage for double-digit growth in 2026 - TradingView
ClearPoint Neuro, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
ClearPoint Neuro (NASDAQ: CLPT) grows 2025 revenue, targets $52–$56M in 2026 - Stock Titan
ClearPoint Neuro Reports Fourth Quarter and Full Year 2025 Results - ACCESS Newswire
Brain-surgery device firm ClearPoint expects $52M–$56M in 2026 sales - Stock Titan
0.00%
0.00%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):